You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

recurrent renal cell cancer

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Bronx, New York (vorinostat,

Terminated
Has Results
  • Recurrent Renal Cell Cancer
  • +2 more
  • Bronx, New York
  • +1 more
Feb 1, 2021

Advanced Bladder Urothelial Carcinoma, Advanced Ureter Urothelial Carcinoma, Metastatic Bladder Urothelial Carcinoma Trial in

Recruiting
  • Advanced Bladder Urothelial Carcinoma
  • +23 more
  • Riverside, California
  • +8 more
Jul 16, 2022

Metastatic Castration-resistant Prostrate Cancer, Renal Cell Carcinoma, Metastatic Melanoma Trial in United States (BMS-936558

Completed
Has Results
  • Metastatic Castration-resistant Prostrate Cancer
  • +3 more
  • BMS-936558 (MDX-1106)
  • Scottsdale, Arizona
  • +12 more
Dec 1, 2021

Recurrent Malignant Solid Tumor, Stage IV Breast Cancer, Stage IV Prostate Cancer Trial in Washington (Canady Helios Cold Plasma

Active, not recruiting
Has Results
  • Recurrent Malignant Solid Neoplasm
  • +15 more
  • Canady Helios Cold Plasma Scalpel
  • Washington, District of Columbia
    Canady Surgical Group PC
Jul 16, 2021

Acute Myeloid Leukemia, Brain Glioblastoma, Estrogen Receptor Negative Trial in Fullerton (Best Practice, Laboratory Biomarker

Active, not recruiting
  • Acute Myeloid Leukemia
  • +66 more
  • Best Practice
  • +3 more
  • Fullerton, California
    Virginia K Crosson Cancer Center
Jan 31, 2022

Relapsed Small Cell Lung Cancer Trial in Beijing (Irinotecan HCl liposome Injection, Topotecan)

Not yet recruiting
  • Relapsed Small Cell Lung Cancer
  • Irinotecan hydrochloride liposome Injection
  • Topotecan
  • Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences
Nov 7, 2023

Imfinzi/Imjudo NSCLC Japan PMS_Japan Post-Marketing Surveillance

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
    • (no location specified)
    Apr 21, 2023

    Advanced Renal Cell Carcinoma Trial (Botensilimab, Balstilimab, Ipilimumab)

    Not yet recruiting
    • Advanced Renal Cell Carcinoma
    • (no location specified)
    Jun 23, 2023

    Head and Neck Carcinoma of Unknown Primary, Locally Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Laryngeal

    Recruiting
    • Head and Neck Carcinoma of Unknown Primary
    • +5 more
    • External Beam Radiation Therapy
    • +4 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Dec 1, 2022

    Recurrent Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v7, Stage IV Renal Cell Cancer AJCC v7 Trial in Bronx, New York

    Completed
    Has Results
    • Recurrent Renal Cell Carcinoma
    • +2 more
    • Bronx, New York
    • +3 more
    Mar 17, 2021

    Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in Chicago, Providence (Nivolumab, Ipilimumab)

    Recruiting
    • Ovarian Cancer
    • +4 more
    • Chicago, Illinois
    • +3 more
    Jan 26, 2023

    Renal Cell Carcinoma Trial in Guangzhou (Pucotenlimab Combined With Lenvatinib)

    Not yet recruiting
    • Renal Cell Carcinoma
    • Pucotenlimab Combined With Lenvatinib
    • Guangzhou, Other (Non U.s.), China
      Sun Yat-sen University Cancer Center
    Nov 10, 2023

    Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Kidney Cancer Trial in Boston (Implantable Microdevice (IMD))

    Not yet recruiting
    • Renal Cell Carcinoma
    • +2 more
    • Implantable Microdevice (IMD)
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Jan 17, 2023

    Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in

    Not yet recruiting
    • Metastatic Lung Non-Small Cell Carcinoma
    • +2 more
    • Cetuximab
    • +2 more
    • Sacramento, California
      University of California Davis Comprehensive Cancer Center
    Oct 2, 2023

    Adrenal Cortex Carcinoma, Alveolar Soft Part Sarcoma, CNS Tumor Trial in United States (Cabozantinib, Cabozantinib S-malate,

    Active, not recruiting
    • Adrenal Cortex Carcinoma
    • +39 more
    • Birmingham, Alabama
    • +142 more
    May 24, 2022

    Renal Cancer Trial in Aarhus N

    Enrolling by invitation
    • Renal Cancer
      • Aarhus N, Denmark
        Urology Department Aarhus University Hospital
      Nov 21, 2023

      Renal Cell Carcinoma Trial in Cleveland (Donor Radical and Partial Nephrectomy, Kidney Transplantation, Laparoscopic Radical

      Not yet recruiting
      • Renal Cell Carcinoma
      • Donor Radical and Partial Nephrectomy
      • +2 more
      • Cleveland, Ohio
        Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
      Feb 15, 2023

      NSCLC Trial in Seoul (Lazertinib/Pemetrexed/Carboplatin)

      Not yet recruiting
      • Non-small Cell Lung Cancer
      • Seoul, Korea, Republic of
        Yonsei University Health System, Severance Hospital
      Mar 23, 2023

      Oligoprogressive Renal Cell Carcinoma Trial in Dallas (Stereotactic ablative body radiation (SABR))

      Active, not recruiting
      • Oligoprogressive Renal Cell Carcinoma
      • Stereotactic ablative body radiation (SABR)
      • Dallas, Texas
        University of Texas Southwestern Medical Center
      Nov 28, 2022

      Ovarian Cancer Trial in Seoul (Cellgram-DC)

      Terminated
      • Ovarian Cancer
      • Cellgram-DC
      • Seoul, Korea, Republic of
        Asan medical center
      Dec 29, 2022

      Metastatic Clear Cell Renal Cell Carcinoma, With Positive PSMA Expression at Tumor Sites Trial (177Lu-PSMA-1

      Not yet recruiting
      • Metastatic Clear Cell Renal Cell Carcinoma
      • With Positive PSMA Expression at Tumor Sites
      • 177Lu-PSMA-1 (radiopharmaceutical)
      • (no location specified)
      Sep 26, 2023

      Hereditary Leiomyomatosis Renal Cell Cancer - Study of Genetic

      Recruiting
      • Renal Tumor Histology
      • +2 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Dec 28, 2022

        NSCLC, Non-small Cell Carcinoma, Histiocytic Tumor Trial (BDTX-4933)

        Not yet recruiting
        • Non-small Cell Lung Cancer
        • +32 more
        • (no location specified)
        Mar 30, 2023

        Renal Cell Carcinoma Trial in Philadelphia (Pembrolizumab infusion, Lenvatinib tablet)

        Not yet recruiting
        • Renal Cell Carcinoma
        • Pembrolizumab infusion
        • Lenvatinib tablet
        • Philadelphia, Pennsylvania
          Abramson Cancer Center at University of Pennsylvania
        Feb 8, 2023

        Renal Cancer Trial in Boston (Dendritic Cell Tumor Fusion Vaccine, Granulocyte Macrophage Colony Stimulating Factor (GM-CSF))

        Active, not recruiting
        Has Results
        • Renal Cancer
        • Dendritic Cell Tumor Fusion Vaccine
        • Granulocyte Macrophage Colony Stimulating Factor (GM-CSF)
        • Boston, Massachusetts
          Beth Israel Deaconess Medical Center
        Jan 2, 2023